成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 16773-42-5 Chemical Structure| 16773-42-5
Chemical Structure| 16773-42-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 16773-42-5

,{[proInfo.pro_purity]}

Ornidazole is an antibiotic used to treat some protozoan infections and investigated for use in Crohn's disease after bowel resection.

Synonyms: Ro 7-0207; NSC 95075; Tiberal

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Ornidazole

CAS No. :16773-42-5
Formula : C7H10ClN3O3
M.W : 219.63
SMILES Code : CC1=NC=C(N1CC(O)CCl)[N+]([O-])=O
Synonyms :
Ro 7-0207; NSC 95075; Tiberal
MDL No. :MFCD00057960
InChI Key :IPWKIXLWTCNBKN-UHFFFAOYSA-N
Pubchem ID :28061

Safety of Ornidazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Application In Synthesis of Ornidazole

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 16773-42-5 ]

[ 16773-42-5 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 32926-43-5 ]
  • [ 16773-42-5 ]
  • (S)-3-chloro-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propane-2-yl-2-amino-3-(4-imidazolyl)propanoate hydrochloride [ No CAS ]
YieldReaction ConditionsOperation in experiment
75.4% In the water bath, N-t-butoxycarbonyl-Nim-triphenylmethyl-histidine (22 mmol, 7.6 g) N,N'-dicyclohexylcarbodiimide (4. 4 mmol, 0.91 g), 4-dimethylamino-pyridine (2. 2 mmol, 0.3 g) And stirred with anhydrous dichloromethane (30 ml). Followed by the addition of L-ornidazole (26mmol, 5.7g) and stirred overnight at room temperature. The insoluble matter was removed by filtration, and the filtrate was evaporated to dryness. The ether was added to the residue and the insoluble impurities in the solution were removed by filtration. The filtrate was concentrated and the column was rapidly passed through ether and the product fractions were collected. The product was concentrated under reduced pressure. The resulting product was added directly to 4MHC1 / dioxane Ring solution (10ml), stirring at room temperature 1h. The solvent was distilled off under reduced pressure and concentrated to dryness. The residue was purified by HPLC (TFA) system to give product 4.3 g; compound 8 yield 75. 4percent.
 

Historical Records

Categories